Low-Dose Ketamine Infusion During Burn Wound Care
Launched by UNIVERSITY OF TENNESSEE · Jul 11, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether adding a low-dose ketamine infusion during burn wound care can help relieve pain more effectively than the current standard treatments, which include medications like fentanyl and midazolam. The goal is to see if ketamine can provide better pain relief, reduce the need for stronger opioid medications, and minimize side effects during treatment for burn injuries.
To participate in this study, patients need to be admitted to a burn service with a thermal injury and be between the ages of 18 and 74. However, there are some exclusions: individuals who cannot consent, cannot communicate their pain levels, are pregnant, or have certain medical conditions that make ketamine unsafe for them will not be eligible. If you join the study, you can expect to receive a low dose of ketamine during your wound care, and the researchers will monitor your pain levels and overall experience to see how well it works. This trial is currently recruiting participants, and it aims to improve pain management for burn injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Admitted to burn service with thermal injury
- Exclusion Criteria:
- • unable/unwilling to consent within 72 hours
- • unable to report NRS
- • known contraindication to ketamine
- • \< than 18 years of age
- • pregnant
- • incarcerated
- • TBSA over 50 %
About University Of Tennessee
The University of Tennessee is a leading research institution dedicated to advancing healthcare through innovative clinical trials. With a commitment to improving patient outcomes and fostering scientific discovery, the university engages in a diverse range of studies that encompass various medical disciplines. Leveraging its extensive resources, expert faculty, and state-of-the-art facilities, the University of Tennessee collaborates with healthcare professionals and industry partners to translate research findings into practical applications. Through rigorous ethical standards and a patient-centered approach, the university aims to contribute significantly to the field of medicine and enhance the well-being of communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Memphis, Tennessee, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported